The House Energy and Commerce Health Subcommittee has announced a series of hearings on FDA user fees for prescription drugs, generic drugs, biosimilar drugs, and medical devices. The hearing schedule is as follows:
- A February 1, 2012 hearing will address reauthorization of the Prescription Drug User Fee Act;
- A February 7 hearing will focus on the new Generic Drug User Fee proposal and Biosimilar User Fee proposal; and
- A February 15 hearing will examine reauthorization of the Medical Device User Fee Act.